Metformin Versus Vildagliptin for Diabetic Hypertensive Patients

Summary

This is a controlled study to measure the efficacy of using metformin or vildagliptin for type 2 diabetic patients who suffers from hypertension to reduce cardiovascular risk resulting from both diabetes and hypertension using different parameters measuring

Timeline

Start

2017-02-01

Primary completion

2017-08-01

Completion

2017-08-01

Drugs

Indications

No indication recorded.